Session Information
SBS 12th Annual Conference & Exhibition
Click here to go to the previous page
Track by Day - September 19, 2006
Track
:
SBS Conference Set
Program Code:
CON2
Description
Session 2A - Hit-To-Lead Case Studies - Michael Sofia & Raju Mohan
Plenary - Fragment-Based Discovery of BCR-ABL Inhibitors for Treatment of Chronic Myelogenous Leukemia - Stephen Burley
Case Studies in the Utilization of Array Synthesis in Hit-to-lead Optimization - R. Michael Lawrence
Physicochemical Profiling & PLS Analysis: Tools to Drive Hit-to-Lead Programs - John W. Ellingboe
Hit-To-Lead Case Studies: Application of ECLiPS in the Discovery of Orally Efficacious MCH1R Antagonists as Antiobesity Agents - Tao Guo
Concept of Focused Diversity: Application to Development of Specific & Dual Inhibitors of VEGFR-2 with in vivo Activity - Alex Kiselyov
Session 2B - Cell & Protein Production: Keeping Pace with Drug Discovery - Tom Kost & Lorenz Mayr
Plenary - Stem Cells: Applications & Opportunities in Modern Drug Discovery - John D. McNeish
Increasing the Output of Eukaryotic Recombinant Protein Expression for High-Throughput Screening - Michael Forstner
Cell as Reagents for HTS & Assay Development - Zhong Zhon
Bacmam Recombinant Baculoviruses in GPCR Drug Discovery - Robert S. Ames
Fueling HTS With Biochemical Assays: A Streamlined Optimization Process - Daniele Carettoni
Session 2C- Advanced Technology for HTS - Scott Diamond & David Weaver
High-Throughput Flow Cytometry for the NIH Roadmap Molecular Libraries Initiative - Larry A. Sklar
Efficient Cell-Based uHTS in 1536-Format: Automated Low-Volume Cell Plate Preparation, High-Density Storage of Compound Solutions & Acoustic Drop Ejection in the Nanoliter Range - Guenther Scheel
Session 2D: Drug Discovery for Diseases of the Developing World - Jose F. Garcia-Bustos, Rashmi Barbhaiya
Plenary - Accelerating the Development of Better TB Drugs - Ken Duncan
Drugs for Neglected Diseases initiative (DNDi) and Neglected Diseases - Robert Don
Genzyme Corporation and Neglected Diseases Drug Discovery and Development - Ted Sybertz
Novel Tyrosine Phosphatase Inhibitors for Treatment of Yersinia Infections - Lutz Tautz
Medicines for Malaria Venture(MMV) - Chris Hentschel
Global Health Forum: Impact of Globalization on Drugs & Diseases - Combating Counterfeit Drugs - Dora Akunyili
Making a Difference on a Global Scale - Nils Daulaire
Developing New Treatments for Killer Diseases - Lynn Marks
Plenary - Fragment-Based Discovery of BCR-ABL Inhibitors for Treatment of Chronic Myelogenous Leukemia - Stephen Burley
Case Studies in the Utilization of Array Synthesis in Hit-to-lead Optimization - R. Michael Lawrence
Physicochemical Profiling & PLS Analysis: Tools to Drive Hit-to-Lead Programs - John W. Ellingboe
Hit-To-Lead Case Studies: Application of ECLiPS in the Discovery of Orally Efficacious MCH1R Antagonists as Antiobesity Agents - Tao Guo
Concept of Focused Diversity: Application to Development of Specific & Dual Inhibitors of VEGFR-2 with in vivo Activity - Alex Kiselyov
Session 2B - Cell & Protein Production: Keeping Pace with Drug Discovery - Tom Kost & Lorenz Mayr
Plenary - Stem Cells: Applications & Opportunities in Modern Drug Discovery - John D. McNeish
Increasing the Output of Eukaryotic Recombinant Protein Expression for High-Throughput Screening - Michael Forstner
Cell as Reagents for HTS & Assay Development - Zhong Zhon
Bacmam Recombinant Baculoviruses in GPCR Drug Discovery - Robert S. Ames
Fueling HTS With Biochemical Assays: A Streamlined Optimization Process - Daniele Carettoni
Session 2C- Advanced Technology for HTS - Scott Diamond & David Weaver
High-Throughput Flow Cytometry for the NIH Roadmap Molecular Libraries Initiative - Larry A. Sklar
Efficient Cell-Based uHTS in 1536-Format: Automated Low-Volume Cell Plate Preparation, High-Density Storage of Compound Solutions & Acoustic Drop Ejection in the Nanoliter Range - Guenther Scheel
Session 2D: Drug Discovery for Diseases of the Developing World - Jose F. Garcia-Bustos, Rashmi Barbhaiya
Plenary - Accelerating the Development of Better TB Drugs - Ken Duncan
Drugs for Neglected Diseases initiative (DNDi) and Neglected Diseases - Robert Don
Genzyme Corporation and Neglected Diseases Drug Discovery and Development - Ted Sybertz
Novel Tyrosine Phosphatase Inhibitors for Treatment of Yersinia Infections - Lutz Tautz
Medicines for Malaria Venture(MMV) - Chris Hentschel
Global Health Forum: Impact of Globalization on Drugs & Diseases - Combating Counterfeit Drugs - Dora Akunyili
Making a Difference on a Global Scale - Nils Daulaire
Developing New Treatments for Killer Diseases - Lynn Marks
